Sponsored
Sponsored
Media Summary: For biotech investors, healthcare innovators, and AI technology enthusiasts — this New to The Street interview from the New York ... For biotech investors, medical innovators, and AI technology leaders — this New to The Street interview from the New York Biotech investors and oncology researchers:

Lantern Pharma Shares Positive Lp - Detailed Analysis & Overview

For biotech investors, healthcare innovators, and AI technology enthusiasts — this New to The Street interview from the New York ... For biotech investors, medical innovators, and AI technology leaders — this New to The Street interview from the New York Biotech investors and oncology researchers: FinancialBuzz.com's latest The Buzz Show: Featuring Our Corporate News Recap on “ 0:00 Introduction 7:40 4th quarter 2024 highlights 29:30 Financial updates 33:45

Photo Gallery

Lantern Pharma Shares Positive LP-184 Phase 1 Cancer Data | Precision Oncology with AI | NewsOut
Lantern Pharma (LTRN) withZETA.ai Demonstration Livecast Replay - April 30, 2026
Lantern Pharma Uses AI to Slash Cancer Drug Timelines | LP-184 Trial Success & Starlight Spinoff
Lantern Pharma Advances Lung Cancer Trial After Positive FDA Feedback
Lantern Pharma Uses AI to Transform Cancer Drug Development | Breakthrough Trials & ZETA Platform
Lantern Pharma advances AI-Driven cancer drug after successful Phase 1a trial
Lantern Pharma Reports Positive LP-184 Cancer Trial Data - Advances Precision Oncology Program
Lantern Pharma Uses AI to Accelerate Cancer Drug Development | FintechTV Interview at the NYSE
Lantern Pharma (Nasdaq: LTRN) | The AI Investor Conference Replay
Lantern Pharma | Second Quarter 2022 Operating & Financial Results Conference Call
Lantern Pharma Raises Capital and Plans AI Spinout Around Zeta Platform
Lantern Pharma | Third Quarter 2022 Operating & Financial Results Conference Call
View Detailed Profile
Lantern Pharma Shares Positive LP-184 Phase 1 Cancer Data | Precision Oncology with AI | NewsOut

Lantern Pharma Shares Positive LP-184 Phase 1 Cancer Data | Precision Oncology with AI | NewsOut

Biotech investors:

Lantern Pharma (LTRN) withZETA.ai Demonstration Livecast Replay - April 30, 2026

Lantern Pharma (LTRN) withZETA.ai Demonstration Livecast Replay - April 30, 2026

Watch our replay of

Sponsored
Lantern Pharma Uses AI to Slash Cancer Drug Timelines | LP-184 Trial Success & Starlight Spinoff

Lantern Pharma Uses AI to Slash Cancer Drug Timelines | LP-184 Trial Success & Starlight Spinoff

For biotech investors, healthcare innovators, and AI technology enthusiasts — this New to The Street interview from the New York ...

Lantern Pharma Advances Lung Cancer Trial After Positive FDA Feedback

Lantern Pharma Advances Lung Cancer Trial After Positive FDA Feedback

Lantern Pharma

Lantern Pharma Uses AI to Transform Cancer Drug Development | Breakthrough Trials & ZETA Platform

Lantern Pharma Uses AI to Transform Cancer Drug Development | Breakthrough Trials & ZETA Platform

For biotech investors, medical innovators, and AI technology leaders — this New to The Street interview from the New York

Sponsored
Lantern Pharma advances AI-Driven cancer drug after successful Phase 1a trial

Lantern Pharma advances AI-Driven cancer drug after successful Phase 1a trial

Lantern Pharma

Lantern Pharma Reports Positive LP-184 Cancer Trial Data - Advances Precision Oncology Program

Lantern Pharma Reports Positive LP-184 Cancer Trial Data - Advances Precision Oncology Program

Biotech investors:

Lantern Pharma Uses AI to Accelerate Cancer Drug Development | FintechTV Interview at the NYSE

Lantern Pharma Uses AI to Accelerate Cancer Drug Development | FintechTV Interview at the NYSE

Investors + biotech analysts:

Lantern Pharma (Nasdaq: LTRN) | The AI Investor Conference Replay

Lantern Pharma (Nasdaq: LTRN) | The AI Investor Conference Replay

At RedChip's AI Investor Conference,

Lantern Pharma | Second Quarter 2022 Operating & Financial Results Conference Call

Lantern Pharma | Second Quarter 2022 Operating & Financial Results Conference Call

Lantern's

Lantern Pharma Raises Capital and Plans AI Spinout Around Zeta Platform

Lantern Pharma Raises Capital and Plans AI Spinout Around Zeta Platform

Lantern Pharma

Lantern Pharma | Third Quarter 2022 Operating & Financial Results Conference Call

Lantern Pharma | Third Quarter 2022 Operating & Financial Results Conference Call

Lantern's

Lantern Pharma | First Quarter 2022 Operating & Financial Results Conference Call

Lantern Pharma | First Quarter 2022 Operating & Financial Results Conference Call

Lantern's

Lantern Pharma (LTRN) Reports Q3 2025 Results | LP-184 Trial Hits All Endpoints

Lantern Pharma (LTRN) Reports Q3 2025 Results | LP-184 Trial Hits All Endpoints

Biotech investors and oncology researchers:

Lantern Pharma Q4 2025 Earnings Call | AI-Driven Pipeline Expansion and Clinical Milestones

Lantern Pharma Q4 2025 Earnings Call | AI-Driven Pipeline Expansion and Clinical Milestones

Lantern Pharma

“The Buzz'' Show: Lantern Pharma (NASDAQ: LTRN) Positive Cancer Collaboration Data

“The Buzz'' Show: Lantern Pharma (NASDAQ: LTRN) Positive Cancer Collaboration Data

FinancialBuzz.com's latest The Buzz Show: Featuring Our Corporate News Recap on “

Lantern Pharma | Fourth Quarter & Year-end 2024 Operating & Financial Results

Lantern Pharma | Fourth Quarter & Year-end 2024 Operating & Financial Results

0:00 Introduction 7:40 4th quarter 2024 highlights 29:30 Financial updates 33:45

Lantern Pharma releases positive Preclinical Data on Efficacy of LP-284 for Mantle Cell Lymphoma

Lantern Pharma releases positive Preclinical Data on Efficacy of LP-284 for Mantle Cell Lymphoma

Lantern Pharma

Inside LP-284: Lantern Pharma’s AI-Guided Approach to B-Cell Lymphomas

Inside LP-284: Lantern Pharma’s AI-Guided Approach to B-Cell Lymphomas

Lantern Pharma

Think Equity Conference 2023 | Overview of Lantern Pharma Inc. (Nasdaq: LTRN) by Panna Sharma

Think Equity Conference 2023 | Overview of Lantern Pharma Inc. (Nasdaq: LTRN) by Panna Sharma

Panna Sharma, CEO and president of

Related Video Content

Lantern | Unlock the full internet information

Lantern is more than a VPN. It's designed to overcome the toughest internet restrictions, surpassing the capabilities...

Lantern · GitHub information

If the App Store is unavailable in your region, you may be able to follow these steps to download Lantern. For stable...

Download Lantern (free) for Windows, macOS, Android, APK, iOS information

May 22, 2026 · Bypass internet restrictions effortlessly with Lantern—a lightweight, user-friendly tool that ensures...

Lantern - Private Internet for All - Amazon Web Services information

Lantern delivers private, fast, reliable and secure access to the open internet. One click to a private and secure...

Lantern Labaton - Home information

Shining a light on corporate wrong. Lantern by Labaton empowers you to get compensation from corporations that have...

Sponsored